ELVN (ELVN) Stock Price & Analysis
ELVN (ELVN) fell 0.55% to USD 59.32 as of September 8, 2026 at 04:23 UTC, according to Nexqual real-time market data.
ELVN last closed at USD 59.32; the session ranged USD 58.97–59.89 on volume of 1,113,062 shares. Market capitalization is —, with a 52-week range of USD 14.79–62.32 (NMS). Source: Nexqual, September 8, 2026 at 04:23 UTC.
Key Statistics (as of September 8, 2026 at 04:23 UTC)
| Price | USD 59.32 |
|---|---|
| Change | ▼ 0.55% (down) |
| Previous Close | USD 59.32 |
| Open | USD 59.32 |
| Day Range | USD 58.97 – 59.89 |
| 52-Week Range | USD 14.79 – 62.32 |
| Volume | 1,113,062 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ELVN)
Nexqual's technical model rates ELVN "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 04:23 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.84 (neutral) |
| vs SMA50 | Above (USD 55.67) |
| MACD | 1.01 (positive) |
From ELVN's Latest SEC 10-K Filing (filed 2026-03-03)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | USD 88.98 | ▲ 2.22% |
| EWTX | Edgewise Therapeutics, Inc. | USD 43.07 | ▲ 2.6% |
| DNTH | Dianthus Therapeutics, Inc. | USD 108.1 | ▲ 1.75% |
| MLYS | Mineralys Therapeutics, Inc. | USD 28.21 | ▼ 2.86% |
| TYRA | Tyra Biosciences, Inc. | USD 28.65 | ▲ 14.01% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:23 UTC. This page is informational and not investment advice.